Observational studyPloS one2021

Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.

Konstantinos Rounis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.